ciprofloxacin and aminolevulinic acid

ciprofloxacin has been researched along with aminolevulinic acid in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Benet, LZ; Brouwer, KL; Chu, X; Dahlin, A; Evers, R; Fischer, V; Giacomini, KM; Hillgren, KM; Hoffmaster, KA; Huang, SM; Ishikawa, T; Keppler, D; Kim, RB; Lee, CA; Niemi, M; Polli, JW; Sugiyama, Y; Swaan, PW; Tweedie, DJ; Ware, JA; Wright, SH; Yee, SW; Zamek-Gliszczynski, MJ; Zhang, L1
Cornelius, JF; El Khatib, M; Giannakis, A; Senger, B; Slotty, PJ; Steiger, HJ1
Cornelius, JF; Gull, HH; Hänggi, D; Karadag, C; Mellert, K; Möller, P; Senger, B; Sorg, RV; Steiger, HJ1

Reviews

1 review(s) available for ciprofloxacin and aminolevulinic acid

ArticleYear
Membrane transporters in drug development.
    Nature reviews. Drug discovery, 2010, Volume: 9, Issue:3

    Topics: Animals; Computer Simulation; Decision Trees; Drug Approval; Drug Discovery; Drug Evaluation, Preclinical; Drug Interactions; Humans; Membrane Transport Proteins; Mice; Mice, Knockout; Prescription Drugs

2010

Other Studies

2 other study(ies) available for ciprofloxacin and aminolevulinic acid

ArticleYear
Enhancing the effect of 5-aminolevulinic acid based photodynamic therapy in human meningioma cells.
    Photodiagnosis and photodynamic therapy, 2014, Volume: 11, Issue:1

    Topics: Aminolevulinic Acid; Cell Line, Tumor; Cell Survival; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Meningeal Neoplasms; Meningioma; Photochemotherapy; Photosensitizing Agents; Time Factors

2014
Ciprofloxacin enhances phototoxicity of 5-aminolevulinic acid mediated photodynamic treatment for chordoma cell lines.
    Photodiagnosis and photodynamic therapy, 2021, Volume: 35

    Topics: Aminolevulinic Acid; Cell Line, Tumor; Cell Survival; Chordoma; Ciprofloxacin; Humans; Photochemotherapy; Photosensitizing Agents

2021